2m 2m 2m 2m 2m 2m 2m
CELCUITY (CELC)
NASDAQ
$65.58+$0.005 (+0.008%)
Price as of Oct 22, 2026 7:30 PM EDT- $3.0BMarket Cap
- -7.09%1-Year Change
- BiotechnologyIndustry
CELCUITY (CELC)
$65.58+$0.005 (+0.008%)
CELC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $65.57 | ||
Change | +$4.01 (+6.51%) | ||
Open | $61.74 | ||
High | $66.93 | ||
Low | $61.74 | ||
Previous Close | $61.56 | ||
Volume | 1,932,805 | ||
30-Day Average Volume | 1,760,762 | ||
1-Week Change | 8.74% | ||
1-Month Change | -22.03% | ||
1-Year Change | -7.09% | ||
3-Year Change | 557.01% | ||
5-Year Change | 273.83% | ||
Fundamentals | |||
Shares Outstanding | 48.9M | ||
Total Assets | $828.2M | ||
Market Cap | $3.0B | ||
Enterprise Value | $3.6B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$55.5M | ||
EBIT | $300,000.00 | ||
EBITDA | $359,000.00 | ||
Net Working Capital | $689.0M | ||
EPS | -$1.44 | ||
Enterprise Value/EBITDA | 9,982 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -43 | ||
PEG | 1 | ||
Price/Free Cash Flow | -54 | ||
Price/Operating Cash Flow | -54 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue